13F HOLDINGS REPORT
M28 Capital Management LP
Quarter ended Q4 2023 · Filed November 13, 2023 · Accession 0000902664-23-005476
Total Value
$87.2M
Positions
11
Other Managers
0
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | WAVE LIFE SCIENCES LTD | WVE | 7,044,500 | $40.5M | 46.45% |
| 2 | INVIVYD INC | IVVD | 9,248,250 | $15.7M | 18.03% |
| 3 | ROCKET PHARMACEUTICALS INC | RCKTW | 523,280 | $10.7M | 12.30% |
| 4 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 197,700 | $4.6M | 5.24% |
| 5 | SILENCE THERAPEUTICS PLC | SLNCF | 363,800 | $3.6M | 4.10% |
| 6 | BRIDGEBIO PHARMA INC | BBIO | 121,200 | $3.2M | 3.67% |
| 7 | CURIS INC | CRIS | 421,951 | $2.8M | 3.19% |
| 8 | PROQR THRAPEUTICS N V | N71542109 | 1,910,600 | $2.5M | 2.85% |
| 9 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 67,400 | $1.8M | 2.08% |
| 10 | TG THERAPEUTICS INC | TGTX | 216,600 | $1.8M | 2.08% |
| 11 | NEXIMMUNE INC | 65344D109 | 133,442 | $28,009 | 0.03% |